easyJet passengers being asked to check themselves for head and neck cancer this summer

Oracle Head & Neck Cancer UK tell holidaymakers to

‘Silence the threat. Give it the check’

easyJet passengers are being asked to check themselves for head and neck cancer this summer as boarding passes provide information about rare cancers.

Oracle Head & Neck Cancer UK has rolled out its messaging on boarding passes for UK travellers visiting major European destinations including Cyprus, Mykonos, Corfu, Benidorm, Antalya and Nice.

Having launched on June 25, an estimated 40,000 passengers are being told to ‘Silence the threat. Give it the check’ in the charity’s latest campaign.

Oracle Head & Neck Cancer UK is the leading charity for head and neck cancer in the UK. The organisation strives to ensure everyone has the best chance of surviving the rare cancers by enabling greater awareness, knowledge and understanding.

As thousands of holidaymakers take flight, it is important to not disregard personal health by mitigating risk factors.

Being mindful of drink and drug intake on holiday can reduce the risk of developing cancer later in life. At the same time, sun cream can protect the skin from UV radiation and keeping up to date with maintaining your oral hygiene can help mitigate risks.

Michelle Vickers, Chief Awareness Officer at Oracle Head & Neck Cancer UK, said:

“It is easy to neglect your health while on holiday, but small steps can help protect you from developing cancer in the long term. Over the next few months, thousands of holidaymakers will see our messaging on easyJet boarding passes with advice as to how to check yourself for the signs for underlying cancer. At Oracle Head & Neck Cancer UK, we are keen to pave the way with our pioneering research while raising awareness of signs and symptoms.”

Every day 34 people are diagnosed with head and neck cancer in the UK, with it being the fourth most common cancer in men.

With only 13% of head and neck cancer patients being diagnosed early, Oracle Head & Neck Cancer UK are attempting to turn the tides on the poor survival and outcomes for patients.